Use of saliva sample to detect C-reactive protein in children with pneumonia

Chih-Min Tsai1, Kuo-Shu Tang1, Ming-Chou Cheng1

  • 1Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.

Insights

Salivary C-reactive protein (CRP) shows promise as a noninvasive biomarker for pediatric pneumonia. This method is simpler and more patient-friendly than traditional blood tests for diagnosing childhood pneumonia.

Area of Science:

  • Pediatric Medicine
  • Biomarker Discovery
  • Inflammatory Disease Diagnostics

Background:

  • Serum C-reactive protein (CRP) is a key inflammation marker for diagnosing pneumonia.
  • Blood sampling for CRP analysis poses challenges in pediatric patients.
  • Salivary analysis offers a noninvasive, patient-friendly alternative for pediatric diagnostics.

Purpose of the Study:

  • To evaluate salivary CRP as a diagnostic biomarker in children with pneumonia.
  • To compare salivary CRP levels with serum CRP levels in pediatric pneumonia patients.
  • To assess the feasibility of using saliva for monitoring pneumonia progression.

Main Methods:

  • Prospective study involving pediatric patients (2-17 years) with pneumonia and healthy controls.
  • Collection of paired saliva and serum samples for CRP analysis at admission and follow-up.
  • Analysis of CRP levels and correlation with clinical status and serum CRP.

Main Results:

  • Salivary CRP levels were significantly higher in children with pneumonia compared to healthy controls (48.77 vs 14.78 ng/mL).
  • Salivary CRP strongly correlated with serum CRP levels in pediatric pneumonia patients (r=0.679).
  • Salivary CRP effectively predicted high serum CRP levels, indicating its potential for monitoring disease severity.

Conclusions:

  • Salivary CRP is a viable alternative to serum CRP for diagnosing pneumonia in children.
  • The noninvasive nature of saliva collection makes it particularly beneficial for pediatric patients.
  • Salivary CRP levels decrease as pneumonia improves, supporting its use in monitoring treatment response.
Abstract